Eko and the National Association of Free & Charitable


OAKLAND, Calif., November 30, 2021 (GLOBE NEWSWIRE) – Eko, a digital cardiopulmonary health company, today announced its partnership with the National Association of Free and Charitable Clinics (ANCA). The partnership will begin with Eko’s donation of smart stethoscopes and telehealth kits to 59 ANCA-affiliated clinics in 33 states. This donation will improve the detection, surveillance and treatment of cardiopulmonary disease for more than 100,000 unique patients in communities severely affected by the health care deficit in the United States.

Eko was founded to enable clinicians to detect and monitor heart and lung disease through its innovative suite of digital tools, patient and provider software, and AI-based analytics. The company reinvented the stethoscope and introduced the world’s first portable digital stethoscope and combined electrocardiogram (ECG). Eko’s FDA-approved AI analysis algorithms help detect abnormal heart rhythms and structural heart disease.

“Eko exists to ensure that all patients have equal access to early detection of heart and lung disease and high quality care that improves and prolongs their lives,” said Connor Landgraf, co-founder and CEO of Eko . “Our commitment to the NAFC will provide their network of clinics with cutting-edge digital tools to detect heart and lung disease with greater accuracy, diagnose with more confidence, manage treatment effectively and, ultimately. account, to give their patients the best possible care. “

ANCA is the only 501c (3) nonprofit organization whose mission is solely focused on the issues and needs of medically underserved people across the country and the 1,400+ free and charitable clinics that serve them.

“The NAFC is delighted to partner with Eko to provide selected clinics with access to this technology that will help expand the virtual care they can provide to their communities,” said Nicole Lamoureux, President and Chief Executive Officer. the leadership of ANCA. “As more and more free and charitable clinics implement and scale up telehealth programs, the possibility of using this technology will expand their reach and capacity, thereby filling the gaps in cardiovascular care in communities vulnerable to the disease. across the country. “

“Thanks to Eko’s generous donation, we are screening patients like never before,” said Joshua Brown, Executive Director of Health Access Inc. “A physical exam at Health Access is now the gateway to confidently screen for heart murmurs and AFib our uninsured and underinsured patients. Eko’s stethoscope technology is already making a difference for many of our patients.

To find out more and refer a friend or colleague, click on here.

About Eko
Eko, a digital cardiopulmonary health company, is improving the way clinicians detect and monitor heart and lung disease with its innovative suite of digital tools, software for patients and providers, and data-driven analytics. ‘IA. Its FDA-approved platform is used by hundreds of thousands of clinicians around the world, enabling them to detect with greater precision, diagnose with more confidence, manage treatment effectively and ultimately account, to give their patients the best possible care. Eko believes that if you can hear clearly, you can confidently care about it. The company is headquartered in Oakland, California. To learn more about Eko, visit ekohealth.com.

About the National Association of Free and Charitable Clinics
Founded in 2001 and based near Washington, DC, ANCA strives to ensure that medically underserved people have access to affordable, quality health care and strives to be a national voice promoting health care. quality health for all. The NAFC has achieved the Platinum Transparency Seal from GuideStar and a four-star rating with Charity Navigator. For more information on ANCA, please visit nafcclinics.org.

Media contact:
alexandra pony
[email protected]
250.858.0656

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/74a2ee1e-8736-4a98-a8bc-8245e1433648


Comments are closed.